OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
Jindong Xie, Yutian Zou, Feng Ye, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 28
Jindong Xie, Yutian Zou, Feng Ye, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer
Song Wu, Jibu Lu, Hongbo Zhu, et al.
Cancer Letters (2023) Vol. 581, pp. 216508-216508
Open Access | Times Cited: 111
Song Wu, Jibu Lu, Hongbo Zhu, et al.
Cancer Letters (2023) Vol. 581, pp. 216508-216508
Open Access | Times Cited: 111
Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature
Yuhui Tang, W. H. Tian, Jindong Xie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Yuhui Tang, W. H. Tian, Jindong Xie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Advances in artificial intelligence to predict cancer immunotherapy efficacy
Jindong Xie, Xiyuan Luo, Xinpei Deng, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 57
Jindong Xie, Xiyuan Luo, Xinpei Deng, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 57
Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review
Diny Dixon, Hina Sattar, Natalia Moros, et al.
Cureus (2024)
Open Access | Times Cited: 40
Diny Dixon, Hina Sattar, Natalia Moros, et al.
Cureus (2024)
Open Access | Times Cited: 40
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
Jindong Xie, W. H. Tian, Yuhui Tang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Jindong Xie, W. H. Tian, Yuhui Tang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
Jindong Xie, Shaoquan Zheng, Yutian Zou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Jindong Xie, Shaoquan Zheng, Yutian Zou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis
Wenlong Chen, Yakun Kang, Wenyi Sheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Wenlong Chen, Yakun Kang, Wenyi Sheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer
Zundong Liu, Mingji Ding, Pengjun Qiu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Zundong Liu, Mingji Ding, Pengjun Qiu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Recent Advances in Artificial Intelligence to Improve Immunotherapy and the Use of Digital Twins to Identify Prognosis of Patients with Solid Tumors
Laura D’Orsi, Biagio Capasso, Giuseppe Lamacchia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11588-11588
Open Access | Times Cited: 4
Laura D’Orsi, Biagio Capasso, Giuseppe Lamacchia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11588-11588
Open Access | Times Cited: 4
Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
Zihang Mai, Jianye Yuan, Hong Yang, et al.
JCI Insight (2022) Vol. 7, Iss. 16
Open Access | Times Cited: 17
Zihang Mai, Jianye Yuan, Hong Yang, et al.
JCI Insight (2022) Vol. 7, Iss. 16
Open Access | Times Cited: 17
Blood coagulation and cancer genes
Nadim Tawil, Janusz Rak
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 1, pp. 101349-101349
Closed Access | Times Cited: 14
Nadim Tawil, Janusz Rak
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 1, pp. 101349-101349
Closed Access | Times Cited: 14
Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients
Mingjie Yuan, Yanfei Jia, Yuanxin Xing, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Mingjie Yuan, Yanfei Jia, Yuanxin Xing, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
A simplified machine learning model utilizing platelet-related genes for predicting poor prognosis in sepsis
Yingying Diao, Yan Zhao, Xinyao Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Yingying Diao, Yan Zhao, Xinyao Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts
Dingshan Deng, Xiaowen Li, Tiezheng Qi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Dingshan Deng, Xiaowen Li, Tiezheng Qi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer
Zhiyong Tan, Shi Fu, Jieming Zuo, et al.
Aging (2023) Vol. 15, Iss. 16, pp. 8384-8407
Open Access | Times Cited: 4
Zhiyong Tan, Shi Fu, Jieming Zuo, et al.
Aging (2023) Vol. 15, Iss. 16, pp. 8384-8407
Open Access | Times Cited: 4
The platelet-related genes associated with the prognosis of HCC by regulating cycling T cell and prolif-TAMs
Chenjia Peng, Ying Wang, Hengbo Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26798-e26798
Open Access | Times Cited: 1
Chenjia Peng, Ying Wang, Hengbo Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26798-e26798
Open Access | Times Cited: 1
Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer
Yutian Zou, Jindong Xie, W. H. Tian, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
Yutian Zou, Jindong Xie, W. H. Tian, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
Yichen Wang, Wenchang Lv, Yi Yi, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3480-3497
Open Access | Times Cited: 3
Yichen Wang, Wenchang Lv, Yi Yi, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3480-3497
Open Access | Times Cited: 3
Characterization of platelet-related genes and constructing signature combined with immune-related genes for predicting outcomes and immunotherapy response in lung squamous cell carcinoma
Siyi Zhao, Han Gong, Wenhua Liang
Aging (2023) Vol. 15, Iss. 14, pp. 6969-6992
Open Access | Times Cited: 3
Siyi Zhao, Han Gong, Wenhua Liang
Aging (2023) Vol. 15, Iss. 14, pp. 6969-6992
Open Access | Times Cited: 3
Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
Xiyun Deng, Chanjuan Zheng, Faqing Tang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Xiyun Deng, Chanjuan Zheng, Faqing Tang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric Cancer
Yan Xia, Xin Lin, Yangyang Cheng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Yan Xia, Xin Lin, Yangyang Cheng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer
D. Dai, Hongkai Zhuang, Mao Shu, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29326-e29326
Open Access
D. Dai, Hongkai Zhuang, Mao Shu, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29326-e29326
Open Access
A platelet-related signature for predicting the prognosis and immunotherapy benefit in bladder cancer based on machine learning combinations
Cheng Chen, Jun Zhang, Xiaoshuang Liu, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 8, pp. 1472-1485
Open Access
Cheng Chen, Jun Zhang, Xiaoshuang Liu, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 8, pp. 1472-1485
Open Access
Tigecycline-induced coagulation gene prognostic prediction model and intestinal flora signature in AML
Feng-luan Zhong, Jiajun He, Kunhao Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Feng-luan Zhong, Jiajun He, Kunhao Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives
Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2024) Vol. 12
Open Access
Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2024) Vol. 12
Open Access
